Category:RANK ligand inhibitors
Jump to navigation
Jump to search
A class of drugs that inhibit the receptor activator of nuclear factor kappa-B ligand (RANKL). Currently Denosumab (Xgeva) is the only FDA-approved drug in this class.
Pages in category "RANK ligand inhibitors"
This category contains only the following page.